|
1
|
Northcott PA, Robinson GW, Kratz CP,
Mabbott DJ, Pomeroy SL, Clifford SC, Rutkowski S, Ellison DW,
Malkin D, Taylor MD, et al: Medulloblastoma. Nat Rev Dis Primers.
5:112019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hovestadt V, Ayrault O, Swartling FJ,
Robinson GW, Pfister SM and Northcott PA: Medulloblastomics
revisited: Biological and clinical insights from thousands of
patients. Nat Rev Cancer. 20:42–56. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Louis DN, Perry A, Wesseling P, Brat DJ,
Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM,
Reifenberger G, et al: The 2021 WHO classification of tumors of the
central nervous system: A summary. Neuro Oncol. 23:1231–1251. 2021.
View Article : Google Scholar
|
|
4
|
Northcott PA, Buchhalter I, Morrissy AS,
Hovestadt V, Weischenfeldt J, Ehrenberger T, Gröbner S, Segura-Wang
M, Zichner T, Rudneva VA, et al: The whole-genome landscape of
medulloblastoma subtypes. Nature. 547:311–317. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Juraschka K and Taylor MD: Medulloblastoma
in the age of molecular subgroups: A review. J Neurosurg Pediatr.
24:353–363. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
DeSouza RM, Jones BR, Lowis SP and Kurian
KM: Pediatric medulloblastoma-update on molecular classification
driving targeted therapies. Front Oncol. 4:1762014. View Article : Google Scholar
|
|
7
|
Maier H, Dalianis T and Kostopoulou ON:
New approaches in targeted therapy for medulloblastoma in children.
Anticancer Res. 41:1715–1726. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Van Ommeren R, Garzia L, Holgado BL,
Ramaswamy V and Taylor MD: The molecular biology of medulloblastoma
metastasis. Brain Pathol. 30:691–702. 2020. View Article : Google Scholar
|
|
9
|
Baudino TA: Targeted cancer therapy: The
next generation of cancer treatment. Curr Drug Discov Technol.
12:3–20. 2015. View Article : Google Scholar
|
|
10
|
Ivanov DP, Coyle B, Walker DA and
Grabowska AM: In vitro models of medulloblastoma: Choosing the
right tool for the job. J Biotechnol. 236:10–25. 2016. View Article : Google Scholar
|
|
11
|
Birks DK, Donson AM, Patel PR, Sufit A,
Algar EM, Dunham C, Kleinschmidt-DeMasters BK, Handler MH, Vibhakar
R and Foreman NK: Pediatric rhabdoid tumors of kidney and brain
show many differences in gene expression but share dysregulation of
cell cycle and epigenetic effector genes. Pediatr Blood Cancer.
60:1095–1102. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Valdora F, Banelli B, Stigliani S, Pfister
SM, Moretti S, Kool M, Remke M, Bai AH, Brigati C, Hielscher T, et
al: Epigenetic silencing of DKK3 in medulloblastoma. Int J Mol Sci.
14:7492–7505. 2013. View Article : Google Scholar
|
|
13
|
Kanchan RK, Perumal N, Atri P, Chirravuri
Venkata R, Thapa I, Klinkebiel DL, Donson AM, Perry D, Punsoni M,
Talmon GA, et al: MiR-1253 exerts tumor-suppressive effects in
medulloblastoma via inhibition of CDK6 and CD276 (B7-H3). Brain
Pathol. 30:732–745. 2020. View Article : Google Scholar
|
|
14
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: A bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar
|
|
17
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chin CH, Chen SH, Wu HH, Ho CW, Ko MT and
Lin CY: cytoHubba: Identifying hub objects and sub-networks from
complex interactome. BMC Syst Biol. 8 (Suppl 4):S112014. View Article : Google Scholar
|
|
20
|
de Bont JM, Kros JM, Passier MM,
Reddingius RE, Sillevis Smitt PA, Luider TM, den Boer ML and
Pieters R: Differential expression and prognostic significance of
SOX genes in pediatric medulloblastoma and ependymoma identified by
microarray analysis. Neuro Oncol. 10:648–660. 2008. View Article : Google Scholar
|
|
21
|
Griesinger AM, Birks DK, Donson AM, Amani
V, Hoffman LM, Waziri A, Wang M, Handler MH and Foreman NK:
Characterization of distinct immunophenotypes across pediatric
brain tumor types. J Immunol. 191:4880–4888. 2013. View Article : Google Scholar
|
|
22
|
Henriquez NV, Forshew T, Tatevossian R,
Ellis M, Richard-Loendt A, Rogers H, Jacques TS, Reitboeck PG,
Pearce K, Sheer D, et al: Comparative expression analysis reveals
lineage relationships between human and murine gliomas and a
dominance of glial signatures during tumor propagation in vitro.
Cancer Res. 73:5834–5844. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ishida Y, Takabatake T, Kakinuma S, Doi K,
Yamauchi K, Kaminishi M, Kito S, Ohta Y, Amasaki Y, Moritake H, et
al: Genomic and gene expression signatures of radiation in
medulloblastomas after low-dose irradiation in Ptch1 heterozygous
mice. Carcinogenesis. 31:1694–1701. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rivero-Hinojosa S, Lau LS, Stampar M,
Staal J, Zhang H, Gordish-Dressman H, Northcott PA, Pfister SM,
Taylor MD, Brown KJ and Rood BR: Proteomic analysis of
medulloblastoma reveals functional biology with translational
potential. Acta Neuropathol Commun. 6:482018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Amani V, Donson AM, Lummus SC, Prince EW,
Griesinger AM, Witt DA, Hankinson TC, Handler MH, Dorris K,
Vibhakar R, et al: Characterization of 2 novel ependymoma cell
lines with chromosome 1q gain derived from posterior fossa tumors
of childhood. J Neuropathol Exp Neurol. 76:595–604. 2017.
View Article : Google Scholar
|
|
26
|
Hooper CM, Hawes SM, Kees UR, Gottardo NG
and Dallas PB: Gene expression analyses of the spatio-temporal
relationships of human medulloblastoma subgroups during early human
neurogenesis. PLoS One. 9:e1129092014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cavalli FMG, Remke M, Rampasek L, Peacock
J, Shih DJH, Luu B, Garzia L, Torchia J, Nor C, Morrissy AS, et al:
Intertumoral heterogeneity within medulloblastoma subgroups. Cancer
Cell. 31:737–754.e6. 2017. View Article : Google Scholar
|
|
28
|
Robinson G, Parker M, Kranenburg TA, Lu C,
Chen X, Ding L, Phoenix TN, Hedlund E, Wei L, Zhu X, et al: Novel
mutations target distinct subgroups of medulloblastoma. Nature.
488:43–48. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Northcott PA, Korshunov A, Witt H,
Hielscher T, Eberhart CG, Mack S, Bouffet E, Clifford SC, Hawkins
CE, French P, et al: Medulloblastoma comprises four distinct
molecular variants. J Clin Oncol. 29:1408–1414. 2011. View Article : Google Scholar
|
|
30
|
Gaudet S, Branton D and Lue RA:
Characterization of PDZ-binding kinase, a mitotic kinase. Proc Natl
Acad Sci USA. 97:5167–5172. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang H, Lee MH, Liu K, Dong Z, Ryoo Z and
Kim MO: PBK/TOPK: An effective drug target with diverse therapeutic
potential. Cancers (Basel). 13:22322021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dougherty JD, Garcia AD, Nakano I,
Livingstone M, Norris B, Polakiewicz R, Wexler EM, Sofroniew MV,
Kornblum HI and Geschwind DH: PBK/TOPK, a proliferating neural
progenitor-specific mitogen-activated protein kinase kinase. J
Neurosci. 25:10773–10785. 2005. View Article : Google Scholar
|
|
33
|
Hovestadt V, Smith KS, Bihannic L, Filbin
MG, Shaw ML, Baumgartner A, DeWitt JC, Groves A, Mayr L, Weisman
HR, et al: Resolving medulloblastoma cellular architecture by
single-cell genomics. Nature. 572:74–79. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ayllón V and O'Connor R: PBK/TOPK promotes
tumour cell proliferation through p38 MAPK activity and regulation
of the DNA damage response. Oncogene. 26:3451–3461. 2007.
View Article : Google Scholar
|
|
35
|
Herbert KJ, Ashton TM, Prevo R, Pirovano G
and Higgins GS: T-LAK cell-originated protein kinase (TOPK): An
emerging target for cancer-specific therapeutics. Cell Death Dis.
9:10892018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kar A, Zhang Y, Yacob BW, Saeed J,
Tompkins KD, Bagby SM, Pitts TM, Somerset H, Leong S, Wierman ME
and Kiseljak-Vassiliades K: Targeting PDZ-binding kinase is
anti-tumorigenic in novel preclinical models of ACC. Endocr Relat
Cancer. 26:765–778. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim DJ, Li Y, Reddy K, Lee MH, Kim MO, Cho
YY, Lee SY, Kim JE, Bode AM and Dong Z: Novel TOPK inhibitor
HI-TOPK-032 effectively suppresses colon cancer growth. Cancer Res.
72:3060–3068. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Joel M, Mughal AA, Grieg Z, Murrell W,
Palmero S, Mikkelsen B, Fjerdingstad HB, Sandberg CJ, Behnan J,
Glover JC, et al: Targeting PBK/TOPK decreases growth and survival
of glioma initiating cells in vitro and attenuates tumor growth in
vivo. Mol Cancer. 14:1212015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu T, Zhang H, Yi S, Gu L and Zhou M:
Mutual regulation of MDM4 and TOP2A in cancer cell proliferation.
Mol Oncol. 13:1047–1058. 2019. View Article : Google Scholar
|
|
40
|
Qiu R, Wu J, Gudenas B, Northcott PA,
Wechsler-Reya RJ and Lu Q: Depletion of kinesin motor KIF20A to
target cell fate control suppresses medulloblastoma tumour growth.
Commun Biol. 4:5522021. View Article : Google Scholar
|
|
41
|
Chandler BC, Moubadder L, Ritter CL, Liu
M, Cameron M, Wilder-Romans K, Zhang A, Pesch AM, Michmerhuizen AR,
Hirsh N, et al: TTK inhibition radiosensitizes basal-like breast
cancer through impaired homologous recombination. J Clin Invest.
130:958–973. 2020. View Article : Google Scholar
|
|
42
|
Zhao Y, He J, Li Y, Lv S and Cui H: NUSAP1
potentiates chemoresistance in glioblastoma through its SAP domain
to stabilize ATR. Signal Transduct Target Ther. 5:442020.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jalalirad M, Haddad TC, Salisbury JL,
Radisky D, Zhang M, Schroeder M, Tuma A, Leof E, Carter JM, Degnim
AC, et al: Aurora-A kinase oncogenic signaling mediates
TGF-β-induced triple-negative breast cancer plasticity and
chemoresistance. Oncogene. 40:2509–2523. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pai VC, Hsu CC, Chan TS, Liao WY, Chuu CP,
Chen WY, Li CR, Lin CY, Huang SP, Chen LT and Tsai KK: ASPM
promotes prostate cancer stemness and progression by augmenting
Wnt-Dvl-3-β-catenin signaling. Oncogene. 38:1340–1353. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yasukawa M, Ando Y, Yamashita T, Matsuda
Y, Shoji S, Morioka MS, Kawaji H, Shiozawa K, Machitani M, Abe T,
et al: CDK1 dependent phosphorylation of hTERT contributes to
cancer progression. Nat Commun. 11:15572020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cheng S, Castillo V and Sliva D: CDC20
associated with cancer metastasis and novel mushroom-derived CDC20
inhibitors with antimetastatic activity. Int J Oncol. 54:2250–2256.
2019.
|
|
47
|
Gao Z, Jia H, Yu F, Guo H and Li B: KIF2C
promotes the proliferation of hepatocellular carcinoma cells in
vitro and in vivo. Exp Ther Med. 22:10942021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Robinson GW, Orr BA, Wu G, Gururangan S,
Lin T, Qaddoumi I, Packer RJ, Goldman S, Prados MD, Desjardins A,
et al: Vismodegib exerts targeted efficacy against recurrent sonic
hedgehog-subgroup medulloblastoma: Results from phase II pediatric
brain tumor consortium studies PBTC-025B and PBTC-032. J Clin
Oncol. 33:2646–2654. 2015. View Article : Google Scholar
|
|
49
|
Kool M, Jones DT, Jäger N, Northcott PA,
Pugh TJ, Hovestadt V, Piro RM, Esparza LA, Markant SL, Remke M, et
al: Genome sequencing of SHH medulloblastoma predicts
genotype-related response to smoothened inhibition. Cancer Cell.
25:393–405. 2014. View Article : Google Scholar
|
|
50
|
Wen H, Chen Z, Li M, Huang Q, Deng Y,
Zheng J, Xiong M, Wang P and Zhang W: An integrative pan-cancer
analysis of PBK in human tumors. Front Mol Biosci. 8:7559112021.
View Article : Google Scholar
|
